Thursday, April 24, 2025 4/24/2025

Interdependence of Antimicrobial and Pro-inflammatory Activities Mediated by S100A12 in the Innate Immune Response

Award Number: R15GM131338
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Description

Interdependence of Antimicrobial and Pro-inflammatory Activities Mediated by S100A12 in the Innate Immune Response - Sequestration of critical nutrients (such as Zn(II), Fe(II) and Mn(II)) during pathogenic invasion is a common strategy undertaken by host cells to thwart infection. In humans, this task is performed by a subset of Ca(II) binding S100 proteins such as S100A12. By chelating Zn(II) at its dimeric interface, S100A12 performs antimicrobial activities. During infection, S100A12 interacts with membrane receptors such as the receptor for advanced glycation end products (RAGE) to initiate a pro-inflammatory signaling cascade. Although known to participate in both antimicrobial and pro-inflammatory activities, the mode of interaction of S100A12 with membrane receptors that initiates inflammatory signaling, is not known. Our research program envisions investigating molecular-level interactions of S100A12 that instigate inflammatory pathways. Our recently reported studies have identified several key features of S100A12 such as (i) the ability of the protein to form reversible oligomeric assemblies that is mostly dominated by Zn(II) binding; (ii) Zn(II) ligation introduced conformational changes to functionally relevant domains of the protein and; (iii) the modulation of Zn(II) sequestration by Ca(II) at physiologically relevant pH conditions. These results, along with previously reported studies in the literature demonstrating the presence of oligomeric S100A12 at inflammatory sites in vivo have laid the foundation of our hypothesis which proposes a metal binding mediated crosstalk between antimicrobial and inflammatory functions of S100A12. Our research program will undertake a biophysical approach to investigate molecular level interactions of S100A12 that afford its functions in the immune response. Focusing on divalent metal ion (Ca(II) and Zn(II)) binding and their influence on S100A12 functions, we propose the following specific aims to test our hypothesis: (i) calcium induced regulation of structure, dynamics and functions; (ii) divalent metal ion mediated signal transduction by S100A12; and (iii) molecular basis of S100A12 interactions in inflammatory responses. These proposed studies will focus on the role of Ca(II) and Zn(II) binding to atomic- and molecular-level details to evaluate the factors influencing S100A12-membrane sensor interactions in vitro. The findings of our work are expected to provide a framework for overall functioning of similar immune system components, allowing for the development of a generalized model of the immune response. Lastly, this work is also expected to generate information that could help develop efficient therapeutic targeting molecules such as S100A12 during aberrant inflammation.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2023 ( Subtotal = $0 )
2023	2022	RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK	2800 VICTORY BLVD	STATEN ISLAND	NY	10314	RICHMOND	USA	Biomedical Research and Research Training	001	2	1/30/2023	COMPETING CONTINUATION	$68,156
2023	2019	RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK	2800 VICTORY BLVD	STATEN ISLAND	NY	10314	RICHMOND	USA	Biomedical Research and Research Training	000	1	1/30/2023	NEW	-$68,156
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = $471,269 )
2022	2022	RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK	2800 VICTORY BLVD	STATEN ISLAND	NY	10314	RICHMOND	USA	Biomedical Research and Research Training	001	2	8/29/2022	COMPETING CONTINUATION	$471,269
2022	2019	RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK	2800 VICTORY BLVD	STATEN ISLAND	NY	10314	RICHMOND	USA	Biomedical Research and Research Training	000	1	8/22/2022	NEW	$0
														Subtotal = $471,269

Issue Date FY: 2019 ( Subtotal = $465,087 )
2019	2019	RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK	2800 VICTORY BLVD	STATEN ISLAND	NY	10314	RICHMOND	USA	Biomedical Research and Research Training	000	1	7/24/2019	NEW	$465,087
														Subtotal = $465,087

Grand Total All Awards = $936,356

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Interdependence of Antimicrobial and Pro-inflammatory Activities Mediated by S100A12 in the Innate Immune Response

Award Number: R15GM131338

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer